138 related articles for article (PubMed ID: 22290693)
41. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
42. Protopathic stimulant use among children with symptoms of ADHD.
Barnard-Brak L; To YM; Fearon DD
Atten Defic Hyperact Disord; 2011 Sep; 3(3):245-51. PubMed ID: 21452045
[TBL] [Abstract][Full Text] [Related]
43. Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder?
Sumner CR; Haynes VS; Teicher MH; Newcorn JH
Postgrad Med; 2010 Sep; 122(5):52-61. PubMed ID: 20861588
[TBL] [Abstract][Full Text] [Related]
44. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
45. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
[TBL] [Abstract][Full Text] [Related]
46. Does prior exposure to stimulants in children with ADHD impact cardiovascular parameters from lisdexamfetamine dimesylate?
Wigal SB; Jun A; Wong AA; Stehli A; Steinberg-Epstein R; Lerner MA
Postgrad Med; 2010 Sep; 122(5):27-34. PubMed ID: 20861585
[TBL] [Abstract][Full Text] [Related]
47. Subtypes of aggression in children with attention deficit hyperactivity disorder: medication effects and comparison with typical children.
King S; Waschbusch DA; Pelham WE; Frankland BW; Corkum PV; Jacques S
J Clin Child Adolesc Psychol; 2009 Sep; 38(5):619-29. PubMed ID: 20183647
[TBL] [Abstract][Full Text] [Related]
48. Growth deficits in children with attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
[TBL] [Abstract][Full Text] [Related]
49. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.
Thiruchelvam D; Charach A; Schachar RJ
J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692
[TBL] [Abstract][Full Text] [Related]
50. Stimulant treatment for children: a community perspective.
Angold A; Erkanli A; Egger HL; Costello EJ
J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):975-84; discussion 984-94. PubMed ID: 10939226
[TBL] [Abstract][Full Text] [Related]
51. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
52. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
Cohen-Zion M; Ancoli-Israel S
Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
[TBL] [Abstract][Full Text] [Related]
53. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
Brackenridge R; McKenzie K; Murray GC; Quigley A
Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
[TBL] [Abstract][Full Text] [Related]
54. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study.
Schubiner H; Hassunizadeh B; Kaczynski R
J Atten Disord; 2006 Nov; 10(2):205-11. PubMed ID: 17085631
[TBL] [Abstract][Full Text] [Related]
55. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report.
Sever Y; Ashkenazi A; Tyano S; Weizman A
Neuropsychobiology; 1997; 35(4):178-80. PubMed ID: 9246217
[TBL] [Abstract][Full Text] [Related]
56. Relation of ferritin levels with symptom ratings and cognitive performance in children with attention deficit-hyperactivity disorder.
Oner O; Alkar OY; Oner P
Pediatr Int; 2008 Feb; 50(1):40-4. PubMed ID: 18279203
[TBL] [Abstract][Full Text] [Related]
57. Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables.
Rucklidge JJ; Eggleston MJF; Darling KA; Stevens AJ; Kennedy MA; Frampton CM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():181-192. PubMed ID: 30217770
[TBL] [Abstract][Full Text] [Related]
58. Ferritin and hyperactivity ratings in attention deficit hyperactivity disorder.
Oner P; Oner O; Azik FM; Cop E; Munir KM
Pediatr Int; 2012 Oct; 54(5):688-92. PubMed ID: 22591427
[TBL] [Abstract][Full Text] [Related]
59. Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth.
Calarge CA; Murry DJ; Ziegler EE; Arnold LE
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):471-7. PubMed ID: 26894929
[TBL] [Abstract][Full Text] [Related]
60. Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder.
Mahmoud MM; El-Mazary AA; Maher RM; Saber MM
Ital J Pediatr; 2011 Dec; 37():60. PubMed ID: 22206662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
